Working… Menu

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03335670
Recruitment Status : Recruiting
First Posted : November 8, 2017
Last Update Posted : April 4, 2019
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Holden Comprehensive Cancer Center
Information provided by (Responsible Party):
Yusuf Menda, University of Iowa